We reported a 51-year-old male electric welder with stage I pneumoconiosis, who had no significant cough, sputum, fever, chest pain, or other discomfort. However, regular physical examination at our hospital revealed bilateral pulmonary nodules with cavity formation. Blood routine, liver or kidney function, and infection-related biomarkers, including interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), and procalcitonin (PCT), were normal. Sputum and alveolar lavage fluid (BALF) acid-fast bacilli (AFB) smears, BALF (TB) PCR, and T-SPOT.TB were negative. The nucleic acid sequence of was detected by BALF metagenomic next-generation sequencing (mNGS), which was confirmed by the subsequent positive culture for NTM. Considering stable conditions, no significant discomfort, and no significant changes in the lung lesion, the patient was diagnosed with inactive nontuberculous mycobacterial pulmonary disease (NTM-PD).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11032163 | PMC |
| http://dx.doi.org/10.2147/IDR.S448805 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Increased Inflammatory Responses in Patients With Active Disseminated Non-Tuberculous Mycobacterial Infection and High Anti-Interferon-Gamma Autoantibodies.
Immune Netw
October 2024
Department of Microbiology, Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.
Article Synopsis
- Adult-onset immunodeficiency (AOID) is linked to anti-IFN-γ autoantibodies (auAbs), which may increase susceptibility to disseminated nontuberculous mycobacterial (dNTM) infections, alongside other molecular factors.
- A study involving dNTM patients assessed plasma anti-IFN-γ auAb levels through ELISA and whole-blood RNA sequencing, showing significantly higher auAb levels in active cases compared to inactive patients and healthy controls.
- The research found that active infection was marked by over-expressed inflammatory pathways, under-expressed type-2 immunity pathways, and elevated plasma IL-8 levels, suggesting IL-8 could potentially serve as a key mediator in
Association of physical inactivity and handgrip strength with non-tuberculous mycobacterial pulmonary disease.
Int J Tuberc Lung Dis
August 2024
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea;, Institute for Immunology and Immunological Disease, Yonsei University College of Medicine, Seoul, Republic of Korea.
The First Case Report of Inactive Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) in a Pneumoconiosis Patient Caused by in China.
Infect Drug Resist
April 2024
Department of Respiratory Medicine, West China Fourth Hospital, Sichuan University, Chengdu, People's Republic of China.
We reported a 51-year-old male electric welder with stage I pneumoconiosis, who had no significant cough, sputum, fever, chest pain, or other discomfort. However, regular physical examination at our hospital revealed bilateral pulmonary nodules with cavity formation. Blood routine, liver or kidney function, and infection-related biomarkers, including interleukin-6 (IL-6), high-sensitivity C-reactive protein (hs-CRP), and procalcitonin (PCT), were normal.
View Article and Find Full Text PDFThe MmpL3 inhibitor MSU-43085 is active in a mouse model of infection.
Microbiol Spectr
January 2024
Department of Microbiology and Molecular Genetics, Michigan State University, East Lansing, Michigan, USA.
MmpL3 is a protein that is required for the survival of bacteria that cause tuberculosis (TB) and nontuberculous mycobacterial (NTM) infections. This report describes the discovery and characterization of a new small molecule, MSU-43085, that targets MmpL3 and is a potent inhibitor of (Mtb) and survival. MSU-43085 is shown to be orally bioavailable and efficacious in an acute model of Mtb infection.
View Article and Find Full Text PDF[A pharmacologic approach to treatment of Mycobacterium abscessus pulmonary disease].
Rev Mal Respir
January 2024
Service de pneumologie, pôle de pathologie thoracique, nouvel hôpital civil, Strasbourg, France; Groupe pour l'enseignement et la recherche en pneumo-infectiologie de la SPLF, 66, boulevard Saint-Michel, 75006 Paris, France.
Mycobacterium abscessus is a fast-growing non-tuberculous mycobacteria complex causing pulmonary infections, comprising the subspecies abscessus, massiliense and bolletii. Differences are based predominantly on natural inducible macrolide resistance, active in most Mycobacterium abscessus spp abscessus species and in Mycobacterium abscessus spp bolletii but inactive in Mycobacterium abscessus spp massiliense. Therapy consists in long-term treatment, combining multiple antibiotics.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!